Table 2.
The mean value of the latency (ms) and amplitude (uV) of N200 and P300 potentials in patients with HT and in the control group.
| ERP | HT patients (n = 68) | Control group (n = 45) | p-value | ||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| Latency (ms) | |||||
| N200 Fz | 246.5 | 34.7 | 211.5 | 20.2 | < 0.001 |
| Cz | 245.6 | 33.7 | 211.3 | 20.6 | < 0.001 |
| Pz | 245.9 | 32.9 | 212.1 | 19.7 | < 0.001 |
| P300 Fz | 351.6 | 22.5 | 322.8 | 21.2 | < 0.001 |
| Cz | 352.1 | 22.7 | 323.5 | 22.3 | < 0.001 |
| Pz | 353.4 | 22.4 | 325.6 | 22.9 | < 0.001 |
| Amplitude (uV) | |||||
| N200 Fz | 3.51 | 2.83 | 4.00 | 2.44 | 0.36 |
| Cz | 3.39 | 2.23 | 3.44 | 2.53 | 0.92 |
| Pz | 2.99 | 2.18 | 3.06 | 1.89 | 0.86 |
| P300 Fz | 5.57 | 3.68 | 8.04 | 3.93 | 0.002 |
| Cz | 5.63 | 3.72 | 8.02 | 3.73 | 0.001 |
| Pz | 5.03 | 3.59 | 7.86 | 3.81 | 0.0001 |
ERP event-related potential, HT Hashimoto’s thyroiditis, SD standard deviation, Fz frontal region, Cz central region, Pz parietal region.